Management of work-related asthma

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 3, 2009, Pages 551-557

  Smith, Andrew M ^a   Bernstein, David I ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

irritant induced asthma; occupational asthma; work exacerbated asthma; Work related asthma

Indexed keywords

ACID ANHYDRIDE; ALLERGEN; BECLOMETASONE DIPROPIONATE; IMMUNOGLOBULIN E ANTIBODY; IRRITANT AGENT; PLACEBO; TOLUENE DIISOCYANATE;

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; WORKER; WORKPLACE;

AIR POLLUTANTS, OCCUPATIONAL; ALLERGENS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IRRITANTS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PRIMARY PREVENTION; WORKPLACE;

EID: 61549120798     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.12.1129     Document Type: Article

References (64)

1. Henneberger P.K., Derk S.J., Sama S.R., Boylstein R.J., Hoffman C.D., Preusse P.A., et al. The frequency of workplace exacerbation among health maintenance organisation members with asthma. Occup Environ Med 63 (2006) 551-557
2. Breton C.V., Zhang Z., Hunt P.R., Pechter E., and Davis L. Characteristics of work related asthma: results from a population based survey. Occup Environ Med 63 (2006) 411-415
3. Lemiere C., Forget A., Dufour M.H., Boulet L.P., and Blais L. Characteristics and medical resource use of asthmatic subjects with and without work-related asthma. J Allergy Clin Immunol 120 (2007) 1354-1359
4. Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein DI, editors. Definition and classification of asthma in the workplace. In: Bernstein IL, Chan-Yeung M, Malo J-L., Bernstein D, editors. Asthma in the workplace and related conditions. 3rd ed. New York: Taylor and Francis Group; 2006. p. 1-8.
5. Bernstein D.I., Cartier A., Cote J., Malo J.L., Boulet L.P., Wanner M., et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 166 (2002) 445-450
6. Tee R.D., Cullinan P., Welch J., Burge P.S., and Newman-Taylor A.J. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 101 (1998) 709-715
7. Pronk A., Preller L., Raulf-Heimsoth M., Jonkers I.C., Lammers J.W., Wouters I.M., et al. Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med 176 (2007) 1090-1097
8. Wisnewski A.V. Developments in laboratory diagnostics for isocyanate asthma. Curr Opin Allergy Clin Immunol 7 (2007) 138-145
9. Brooks S.M., Weiss M.A., and Bernstein I.L. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 88 (1985) 376-384
10. Brooks S.M., Hammad Y., Richards I., Giovinco-Barbas J., and Jenkins K. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 113 (1998) 42-49
11. Menzies D., Nair A., Williamson P.A., Schembri S., Al-Khairalla M.Z., Barnes M., et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA 296 (2006) 1742-1748
12. Medina-Ramon M., Zock J.P., Kogevinas M., Sunyer J., Basagana X., Schwartz J., et al. Short-term respiratory effects of cleaning exposures in female domestic cleaners. Eur Respir J 27 (2006) 1196-1203
13. Blanc P.D., and Toren K. How much adult asthma can be attributed to occupational factors?. Am J Med 107 (1999) 580-587
14. Balmes J., Becklake M., Blanc P., Henneberger P., Kreiss K., Mapp C., et al. American Thoracic Society statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 167 (2003) 787-797
15. Kogevinas M., Zock J.P., Jarvis D., Kromhout H., Lillienberg L., Plana E., et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 370 (2007) 336-341
16. Goe S.K., Henneberger P.K., Reilly M.J., Rosenman K.D., Schill D.P., Valiante D., et al. A descriptive study of work aggravated asthma. Occup Environ Med 61 (2004) 512-517
17. Rosenman K.D., Reilly M.J., and Kalinowski D.J. A state-based surveillance system for work-related asthma. J Occup Environ Med 39 (1997) 415-425
18. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
19. Tarlo S.M., Balmes J., Balkissoon R., Beach J., Bernstein D., Blanc P.D., et al. ACCP consensus statement: diagnosis and management of work-related asthma. Chest 134 3 suppl (2008) 1S-41S
20. Nicholson P.J., Cullinan P., Taylor A.J., Burge P.S., and Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 62 (2005) 290-299
21. Newman Taylor A.J., Cullinan P., Burge P.S., Nicholson P., and Boyle C. BOHRF guidelines for occupational asthma. Thorax 60 (2005) 364-366
22. Malo J.L., Ghezzo H., L'Archeveque J., Lagier F., Perrin B., and Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma?. Am Rev Respir Dis 143 (1991) 528-532
23. Expert Panel Report 3 (EPR-3). guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120 (2007) S94-S138
24. Perkner J.J., Fennelly K.P., Balkissoon R., Bartelson B.B., Ruttenber A.J., Wood II R.P., et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med 40 (1998) 136-143
25. Mapp C.E., Boschetto P., Maestrelli P., and Fabbri L.M. Occupational asthma. Am J Respir Crit Care Med 172 (2005) 280-305
26. Yacoub M.R., Lavoie K., Lacoste G., Daigle S., L'Archeveque J., Ghezzo H., et al. Assessment of impairment/disability due to occupational asthma through a multidimensional approach. Eur Respir J 29 (2007) 889-896
27. Vandenplas O., Toren K., and Blanc P.D. Health and socioeconomic impact of work-related asthma. Eur Respir J 22 (2003) 689-697
28. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) (2006). http://www.ginasthma.com/ Accessed December 1, 2008
29. Anees W., Moore V.C., and Burge P.S. FEV1 decline in occupational asthma. Thorax 61 (2006) 751-755
30. Gautrin D., Ghezzo H., Infante-Rivard C., Magnan M., L'Archeveque J., Suarthana E., et al. Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents. Am J Respir Crit Care Med 177 (2008) 871-879
31. Baur X. I are we closer to developing threshold limit values for allergens in the workplace?. Ann Allergy Asthma Immunol 90 (2003) 11-18
32. LaMontagne A.D., Radi S., Elder D.S., Abramson M.J., and Sim M. Primary prevention of latex related sensitisation and occupational asthma: a systematic review. Occup Environ Med 63 (2006) 359-364
33. Schweigert M.K., Mackenzie D.P., and Sarlo K. Occupational asthma and allergy associated with the use of enzymes in the detergent industry-a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy 30 (2000) 1511-1518
34. Jeal H., Draper A., Harris J., Taylor A.N., Cullinan P., and Jones M. Modified Th2 responses at high-dose exposures to allergen: using an occupational model. Am J Respir Crit Care Med 174 (2006) 21-25
35. Matsui E.C., Diette G.B., Krop E.J., Aalberse R.C., Smith A.L., Curtin-Brosnan J., et al. Mouse allergen-specific immunoglobulin G and immunoglobulin G4 and allergic symptoms in immunoglobulin E-sensitized laboratory animal workers. Clin Exp Allergy 35 (2005) 1347-1353
36. Matsui E.C., Diette G.B., Krop E.J., Aalberse R.C., Smith A.L., and Eggleston P.A. Mouse allergen-specific immunoglobulin G4 and risk of mouse skin test sensitivity. Clin Exp Allergy 36 (2006) 1097-1103
37. Malo J.L., Cartier A., Cote J., Milot J., Leblanc C., Paquette L., et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med 153 (1996) 953-960
38. Maestrelli P., De Marzo N., Saetta M., Boscaro M., Fabbri L.M., and Mapp C.E. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma: placebo-controlled study of subjects sensitized to toluene diisocyanate. Am Rev Respir Dis 148 (1993) 407-412
39. Carino M., Aliani M., Licitra C., Sarno N., and Ioli F. Death due to asthma at workplace in a diphenylmethane diisocyanate-sensitized subject. Respiration 64 (1997) 111-113
40. Ehrlich R.I. Fatal asthma in a baker: a case report. Am J Ind Med 26 (1994) 799-802
41. Fabbri L.M., Danieli D., Crescioli S., Bevilacqua P., Meli S., Saetta M., et al. Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis 137 (1988) 1494-1498
42. Klusackova P., Pelclova D., Jindriska Levedova D., Mareckova H., and Brabec M. Occupational asthma after withdrawal from the occupational allergen exposure. Ind Health 44 (2006) 629-638
43. Rachiotis G., Savani R., Brant A., MacNeill S.J., Newman Taylor A., and Cullinan P. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 62 (2007) 147-152
44. Bernstein D.I., Korbee L., Stauder T., Bernstein J.A., Scinto J., Herd Z.L., et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 92 (1993) 387-396
45. Park H.S., Lee S.K., Kim H.Y., Nahm D.H., and Kim S.S. Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Clin Exp Allergy 32 (2002) 551-555
46. Muller-Wening D., and Neuhauss M. Protective effect of respiratory devices in farmers with occupational asthma. Eur Respir J 12 (1998) 569-572
47. Grammer L.C., Harris K.E., and Yarnold P.R. Effect of respiratory protective devices on development of antibody and occupational asthma to an acid anhydride. Chest 121 (2002) 1317-1322
48. Liu Y., Stowe M.H., Bello D., Woskie S.R., Sparer J., Gore R., et al. Respiratory protection from isocyanate exposure in the autobody repair and refinishing industry. J Occup Environ Hyg 3 (2006) 234-249
49. Banks D.E., Rando R.J., and Barkman Jr. H.W. Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures. Chest 97 (1990) 121-125
50. Vandenplas O., Jamart J., Delwiche J.P., Evrard G., and Larbanois A. Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of exposure. J Allergy Clin Immunol 109 (2002) 125-130
51. Bernstein D.I. Management of natural rubber latex allergy. J Allergy Clin Immunol 110 2 suppl (2002) S111-S116
52. Quirce S., Gala G., Perez-Camo I., Sanchez-Fernandez C., Pacheco A., and Losada E. Irritant-induced asthma: clinical and functional aspects. J Asthma 37 (2000) 267-274
53. Jaakkola M.S., and Jaakkola J.J. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. Eur Respir J 28 (2006) 397-408
54. Ohman Jr. J.L., Findlay S.R., and Leitermann K.M. Immunotherapy in cat-induced asthma: double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 74 (1984) 230-239
55. Walker S.M., Pajno G.B., Lima M.T., Wilson D.R., and Durham S.R. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 107 (2001) 87-93
56. Sussman G.L., Beezhold D.H., and Liss G. Latex allergy: historical perspective. Methods 27 (2002) 3-9
57. Leynadier F., Herman D., Vervloet D., and Andre C. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 106 (2000) 585-590
58. Sastre J., Fernandez-Nieto M., Rico P., Martin S., Barber D., Cuesta J., et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 111 (2003) 985-994
59. Armentia A., Martin-Santos J.M., Quintero A., Fernandez A., Barber D., Alonso E., et al. Bakers' asthma: prevalence and evaluation of immunotherapy with a wheat flour extract. Ann Allergy 65 (1990) 265-272
60. Susitaival P., Kirk J.H., and Schenker M.B. Atopic symptoms among California veterinarians. Am J Ind Med 44 (2003) 166-171
61. Pichler C.E., Helbling A., and Pichler W.J. Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 56 (2001) 301-306
62. Pifferi M., Baldini G., Marrazzini G., Baldini M., Ragazzo V., Pietrobelli A., et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 57 (2002) 785-790
63. Maestrelli P., Zanolla L., Pozzan M., and Fabbri L.M. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite. J Allergy Clin Immunol 113 (2004) 643-649
64. Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 147 (1993) 1056-1061